Can I Take Saw Palmetto With Trulicity (Dulaglutide)?

What Is Trulicity and What Does It Do in the Body?

Trulicity is the brand name for dulaglutide, a once-weekly injectable GLP-1 receptor agonist approved by the FDA in 2014 for type 2 diabetes and, subsequently, for cardiovascular risk reduction in adults with established cardiovascular disease or multiple risk factors. [1] It works by mimicking glucagon-like peptide-1, stimulating glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite. [2]

How Dulaglutide Is Metabolized

Dulaglutide is a large peptide molecule. It is broken down through standard proteolytic pathways, not through the cytochrome P450 (CYP450) enzyme system that governs metabolism of most small-molecule drugs and many herbal compounds. [3] This matters because the majority of herb-drug interactions documented in the literature involve CYP450 modulation. Dulaglutide bypasses that system almost entirely.

The half-life of dulaglutide is approximately 5 days. Peak plasma concentration occurs 24 to 72 hours after subcutaneous injection. Renal excretion of intact drug is minimal. [3]

Clinical Efficacy Context

In the AWARD-11 trial (N=1,842), dulaglutide 4.5 mg once weekly reduced HbA1c by 1.77 percentage points from a baseline of approximately 8.6% at 52 weeks, compared with a 1.38 percentage-point reduction with the 1.5 mg dose (P<0.001). [4] The REWIND cardiovascular outcomes trial (N=9,901) demonstrated a 12% relative risk reduction in major adverse cardiovascular events over a median follow-up of 5.4 years. [5]

What Is Saw Palmetto and Why Do People Take It?

Saw palmetto is a standardized extract from the fruit of Serenoa repens, a small palm native to the southeastern United States. It is one of the most widely purchased herbal supplements in North America, used primarily by men experiencing lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). [6]

Mechanism of Action of Saw Palmetto

The proposed mechanisms include:

• 5-alpha-reductase (5-AR) inhibition, reducing conversion of testosterone to dihydrotestosterone (DHT)
• Anti-inflammatory activity, partially through inhibition of cyclooxygenase and 5-lipoxygenase pathways
• Mild antiplatelet effect, observed in vitro and in several case reports

A 2011 Cochrane review by Tacklind et al. Covering 32 trials (N=5,666) found that saw palmetto did not improve urinary symptom scores compared to placebo, though it continued to be used widely based on older trial data. [7] The Complementary and Alternative Medicine for Urological Symptoms (CAMUS) trial (N=369), published in JAMA, confirmed that saw palmetto extract at up to three times the standard dose did not reduce lower urinary tract symptoms more than placebo over 72 weeks. [8]

Who Actually Takes Saw Palmetto

Despite mixed efficacy data, an estimated 2.5 million American men used saw palmetto in 2022, according to the National Health Interview Survey supplement data compiled by the National Center for Complementary and Integrative Health. [9] Given the significant overlap between BPH prevalence and the type 2 diabetes population (men over 50 account for a large share of both groups), the clinical question of combining saw palmetto with Trulicity is genuinely common.

Is There a Direct Drug Interaction Between Saw Palmetto and Trulicity?

No published clinical trial, pharmacokinetic study, or high-quality case series has documented a direct pharmacokinetic interaction between saw palmetto and dulaglutide. This is the most important point to understand about this combination.

Why a Direct PK Interaction Is Unlikely

Dulaglutide does not rely on CYP450 enzymes for its metabolism. Saw palmetto's known drug interactions in the literature are almost exclusively mediated through CYP3A4, CYP2D6 inhibition, or antiplatelet pathways. Because these pathways do not govern dulaglutide's clearance or activation, the standard mechanism by which herbal supplements alter drug blood levels simply does not apply here. [3][10]

For comparison, saw palmetto has a documented (though mild) interaction with warfarin through the anticoagulant pathway, and a potential interaction with antiplatelet agents such as aspirin or clopidogrel. Those interactions involve pharmacodynamic overlap, not changes to drug metabolism. [10]

Gastric Emptying: One Theoretical Consideration

Dulaglutide slows gastric emptying, and this effect is most pronounced in the first 4 to 8 weeks of treatment. Slowed gastric emptying can, in theory, alter the absorption of orally administered supplements and drugs by changing the rate (though not always the total extent) of absorption. This is a class effect of GLP-1 receptor agonists rather than anything specific to the saw palmetto combination. [11]

The clinical relevance for saw palmetto is low. Saw palmetto is a fat-soluble extract typically taken with food, and its absorption is not highly time-sensitive. No data suggest that the gastric-emptying effect of dulaglutide materially changes saw palmetto bioavailability.

The Two Indirect Concerns That Do Matter Clinically

While a direct pharmacokinetic clash is unlikely, two indirect pharmacodynamic concerns deserve attention.

1. Saw Palmetto's Anticoagulant and Antiplatelet Activity

Saw palmetto has been associated with bleeding in case reports. A 2007 case report published in the Annals of Internal Medicine described significant intraoperative bleeding in a patient taking saw palmetto, prompting the authors to recommend discontinuation 2 weeks before elective surgery. [12] A separate report documented spontaneous bleeding in a patient taking saw palmetto combined with clopidogrel.

Dulaglutide itself does not have anticoagulant properties. However, many patients on Trulicity also take aspirin (given its cardiovascular indication) or other antiplatelets as part of standard diabetes care. If saw palmetto is added to that regimen, the cumulative antiplatelet burden increases. [5]

Practical guidance:

• Inform your surgeon or proceduralist that you take saw palmetto at least 2 weeks before any planned procedure.
• If you are on aspirin plus dulaglutide, discuss the addition of saw palmetto explicitly with your prescriber before starting it.
• Monitor for unexplained bruising, prolonged bleeding from minor cuts, or nosebleeds.

2. Hormonal Effects and Relevance to Metabolic Health

Saw palmetto inhibits 5-AR, which reduces DHT. In men with type 2 diabetes already at risk for lower testosterone levels, this mild anti-androgenic effect is worth acknowledging. Low testosterone is independently associated with insulin resistance, and pharmaceutical 5-AR inhibitors (finasteride, dutasteride) carry FDA label warnings about sexual side effects. [13]

Saw palmetto's effect on DHT is considerably weaker than pharmaceutical 5-AR inhibitors. A 2001 study by Marks et al. In the Journal of Urology (N=44) found that saw palmetto did not significantly reduce intraprostatic DHT at standard doses, in contrast to finasteride. [14] Still, patients combining Trulicity with saw palmetto who notice changes in libido, energy, or mood should mention both agents to their prescriber.

Does Saw Palmetto Affect Blood Sugar or Insulin Sensitivity?

No strong clinical trial has shown that saw palmetto meaningfully alters fasting glucose, postprandial glucose, or HbA1c. Some preclinical (animal) data suggest minor anti-inflammatory effects that could theoretically improve insulin signaling, but these findings have not been replicated in humans at clinically relevant doses. [15]

This means that adding saw palmetto to a Trulicity regimen is unlikely to require any adjustment to dulaglutide dosing or to change the frequency of glucose monitoring. Patients should maintain their existing monitoring schedule as recommended by their diabetes care team.

What the Guidelines and Interaction Databases Say

No major diabetes guideline from the American Diabetes Association (ADA), the American Association of Clinical Endocrinology (AACE), or the FDA specifically addresses the dulaglutide-saw palmetto combination. The FDA label for Trulicity lists no herbal interactions because none have been established through pharmacokinetic studies submitted during the approval process. [1]

The Natural Medicines Database (Therapeutic Research Center), the most widely used clinical reference for herb-drug interactions among pharmacists and physicians, rates saw palmetto interactions using a severity and evidence-quality scoring system. As of its most recent update, saw palmetto combined with anticoagulant or antiplatelet drugs carries a "moderate" interaction rating with "fair" evidence quality, based primarily on the case report literature. Its combination with GLP-1 receptor agonists is rated "insufficient evidence," meaning no interaction has been identified but data are sparse. [10]

The American Diabetes Association's 2024 Standards of Care in Diabetes state: "Providers should ask patients about the use of complementary and alternative medicine, including dietary supplements, as these may interact with diabetes medications or affect glucose control." [16] This is not a statement about saw palmetto specifically, but it underscores the importance of disclosure.

A Practical Decision Framework for Clinicians and Patients

The following framework summarizes the clinical approach when a patient taking dulaglutide asks about saw palmetto:

| Question | Answer | |---|---| | Is there a direct PK interaction? | No evidence to suggest one | | Does saw palmetto change blood sugar? | No clinically meaningful effect documented | | Is there a bleeding concern? | Yes, mild. Heightened if aspirin or other antiplatelets are co-prescribed | | Should dose timing be separated? | No evidence that separation reduces the indirect risks | | Should the patient stop one agent? | Not automatically; discuss risk/benefit with prescriber | | Pre-procedure action needed? | Stop saw palmetto 2 weeks before surgery |

Monitoring Plan if You Are Already Taking Both

If you are already taking Trulicity and saw palmetto and only now reading this, the appropriate step is not to abruptly stop either agent. Abruptly stopping dulaglutide can cause glycemic deterioration, and stopping saw palmetto mid-course has no established clinical protocol for tapering.

What to Watch For

Watch for these signs and report them to your care team:

• Unexplained bruising or prolonged bleeding from minor wounds
• Blood in urine (hematuria), which can occasionally occur with BPH and may be complicated by antiplatelet activity
• Significant changes in energy, libido, or mood (potential hormonal signal)
• Gastrointestinal side effects that worsen after adding saw palmetto (nausea, bloating), given that dulaglutide already affects gastric motility

Lab Monitoring Considerations

No additional lab work is specifically required for this combination in stable patients. However, if you are also on warfarin, regular INR checks are already part of standard care. The addition of saw palmetto is one reason to ensure INR remains stable after any regimen change. For patients not on anticoagulants, routine HbA1c checks every 3 months (as recommended for patients not yet at glycemic goal) remain the primary monitoring tool. [16]

Practical Tips for Patients

Saw palmetto is widely available over the counter, and many patients do not think of it as a "real" medication. This leads to under-reporting when clinicians ask about current medications.

A few straightforward steps reduce your risk:

1. Tell your prescriber and pharmacist that you take saw palmetto every time your medication list is reviewed. Include the dose and brand.
2. Check the standardization on your saw palmetto bottle. Products standardized to 85% to 95% fatty acids and sterols are the most studied formulations. Non-standardized products vary widely in potency.
3. Take saw palmetto with the largest meal of the day. Fat improves absorption of its lipophilic components, and food co-administration has been shown to reduce gastrointestinal discomfort. This does not need to be timed around your weekly Trulicity injection.
4. Plan ahead for procedures. Two weeks before any dental extraction, colonoscopy, or surgical procedure, discuss whether to pause saw palmetto with your proceduralist.
5. Do not use saw palmetto as a replacement for finasteride or dutasteride if your urologist has recommended a pharmaceutical 5-AR inhibitor. The efficacy difference is substantial.

Special Populations: Considerations Beyond the Average Patient

Women Taking Trulicity

Saw palmetto is sometimes used by women for hormonal conditions including polycystic ovary syndrome (PCOS), though evidence for this indication is limited. Women of reproductive age who take saw palmetto alongside dulaglutide should be aware that saw palmetto's anti-androgenic properties are pharmacologically active in women. Animal studies have raised concerns about fetal exposure, and dulaglutide itself carries a category D-equivalent warning for pregnancy. Both agents should be discontinued before planned pregnancy. [1][17]

Older Adults

Men over 65 make up a large portion of both the BPH population and the type 2 diabetes population. Older adults are more likely to be on aspirin, clopidogrel, or other antiplatelets alongside Trulicity for cardiovascular risk management. In this group, the additive antiplatelet concern from saw palmetto carries more weight. A conservative approach is warranted: confirm with your cardiologist or internist before adding saw palmetto to an already complex regimen.

Patients With Chronic Kidney Disease

Dulaglutide does not require dose adjustment for renal impairment (its clearance is not renally dependent), but patients with CKD are often on multiple medications and may have altered hemostasis. Saw palmetto's bleeding risk, while modest, is worth discussing in this context.

The Bottom Line

No clinically documented pharmacokinetic interaction exists between saw palmetto and dulaglutide (Trulicity). The combination's primary concern is pharmacodynamic: saw palmetto's mild antiplatelet activity can add to the bleeding burden in patients already taking aspirin or other antiplatelets as part of their cardiovascular care alongside Trulicity. Hormonal effects are secondary and modest at standard doses. Patients stable on both agents should disclose this combination to their prescriber, monitor for unusual bleeding, and stop saw palmetto at least 14 days before any planned surgical or invasive procedure per standard perioperative guidance. [12]